Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | WRN | Q14191 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19784554 | 0.83 | NAAA (0.41) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL20299318 | 0.81 | NAAA (0.40) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL11208718 | 0.78 | NAAA (0.41) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL28082567 | 0.76 | NAAA (0.40) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL19784550 | 0.76 | DGKA (0.60) | ALDH1A1 | |
| SCHEMBL230663 | 0.74 | — | — | |
| SCHEMBL28082607 | 0.73 | NAAA (0.41) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL11615310 | 0.72 | ALDH1A1 (0.43) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL30705379 | 0.71 | NAAA (0.40) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL28082406 | 0.71 | NAAA (0.40) | NAAAALDH1A1CYP1A2HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240222629-A1 | SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF | SEMICONDUCTOR ENERGY LAB (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20210104744-A1 | SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-04-08 | — | — | US | disclosed |
| US-20180076489-A1 | ELECTRODE AND POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-03-15 | — | — | US | disclosed |
| US-20180019462-A1 | Graphene Compound, Method for Forming Graphene Compound, and Power Storage Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180076489-A1 | ELECTRODE AND POWER STORAGE DEVICE | SELENOI, SOD1, L1CAM | NAAA 740/4885ALDH1A1 2875/4885CYP1A2 3989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.